Skip to search formSkip to main contentSkip to account menu

imidapril

Known as: (S)-3-(N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl)-1-methyl-2-oxoimidazoline-4-carboxylic acid, 1-methyl-3-(2-(N-(1-ethoxycarbonyl-3-phenylpropyl)amino)propionyl)-2-oxoimidazolidine-4-carboxylic acid, 4-Imidazolidinecarboxylic acid, 3-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, monohydrochloride, (4S-(3(R*(R*)),4R*))- 
An angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, imidapril is converted by hydrolysis in the liver into… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
To examine the involvement of (pro)renin receptor in the accelerated organ damage in streptozotocin-induced diabetic male SHRsp… 
2006
2006
Left ventricular hypertrophy is considered to be a major cardiovascular risk factor in hemodialysis patients. Not only high blood… 
2004
2004
Objective This study was designed to investigate whether chronic angiotensin-converting enzyme (ACE) inhibition prevents… 
Highly Cited
2003
Highly Cited
2003
The activities of cardiac protein kinase C (PKC) were examined in hemodynamically assessed rats subsequent to myocardial… 
2000
2000
Summary Inhibitors of angiotensin converting enzyme (ACE) have been developed recently for therapeutic purposes in hypertension… 
1999
1999
1. The role of angiotensin (Ang)II in and the effects of angiotensin‐converting enzyme (ACE) inhibitors on the regulation of… 
1998
1998
Background: Various angiotensin-converting enzyme inhibitors are known to improve heart function and prolong survival in patients… 
1992
1992
Imidapril is a newly synthesized non-sulfhydryl-containing angiotensin I converting enzyme (ACE) inhibitor. The present study…